financetom
Business
financetom
/
Business
/
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
Jul 24, 2024 4:34 AM

07:02 AM EDT, 07/24/2024 (MT Newswires) -- Travel + Leisure ( TNL ) reported Q2 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.33 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Net revenue for the quarter ended on June 30 was $985 million, up from $949 million a year earlier.

Analysts surveyed by Capital IQ expected $987.2 million.

The company expects Q3 adjusted EBITDA of $235 million to $245 million. Analysts polled by Capital IQ expect $238.7 million. The company updated its full-year adjusted EBITDA to a new range of $915 million to $935 million versus the prior outlook of $910 million to $930 million. Analysts polled by Capital IQ expect $921.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BP wins arbitration case against Venture Global over LNG cargoes
BP wins arbitration case against Venture Global over LNG cargoes
Oct 9, 2025
HOUSTON, Oct 9 (Reuters) - BP has won its arbitration case against Venture Global ( VG ) over the U.S. supplier's failure to deliver liquefied natural gas under a long-term contract that was due to start in late 2022, Venture Global ( VG ) said on Thursday. ...
Zivo Bioscience Insider Bought Shares Worth $284,421, According to a Recent SEC Filing
Zivo Bioscience Insider Bought Shares Worth $284,421, According to a Recent SEC Filing
Oct 9, 2025
04:33 PM EDT, 10/09/2025 (MT Newswires) -- Christopher D. Maggiore, 10% Owner, Director, on October 08, 2025, executed a purchase for 23,682 shares in Zivo Bioscience ( ZIVO ) for $284,421. Following the Form 4 filing with the SEC, Maggiore has control over a total of 517,526 common shares of the company, with 517,526 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1101026/000165495425011614/xslF345X05/section16.xml...
Applied Digital Fiscal Q1 Non-GAAP Loss Widens, Revenue Rises
Applied Digital Fiscal Q1 Non-GAAP Loss Widens, Revenue Rises
Oct 9, 2025
04:34 PM EDT, 10/09/2025 (MT Newswires) -- Applied Digital ( APLD ) reported a fiscal Q1 adjusted net loss late Thursday of $0.03 per diluted share, widening from the loss of $0.01 a year earlier. Four analysts polled by FactSet expected a loss of $0.16. Revenue in the three months ended Aug. 31 rose to $64.2 million from $34.8 million...
USANA Health Sciences Preliminary Q3 Swings to Loss, Net Sales Rise
USANA Health Sciences Preliminary Q3 Swings to Loss, Net Sales Rise
Oct 9, 2025
04:33 PM EDT, 10/09/2025 (MT Newswires) -- USANA Health Sciences ( USNA ) reported fiscal Q3 preliminary adjusted loss late Thursday of $0.15, swinging from earnings of $0.56 a year earlier. Two analysts polled by FactSet expected earnings of $0.56. Preliminary net sales for the quarter ended Sept. 27 were $214 million, up from $200 million a year earlier. Two...
Copyright 2023-2026 - www.financetom.com All Rights Reserved